ND-630

Catalog #
27071-1
$175 *
Size: 1 mg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

ND-630 (NDI 010976) is a highly specific, reversible inhibitor of ACC1 (IC50 = 2 nM) and ACC2 (IC50 = 6 nM). ND-630 interacts within the ACC phosphopeptide acceptor and dimerization site to prevent dimerization of ACC. Because the dimerization site is not conserved among other mammalian carboxylases, ND-630 lacks the ability to inhibit other mechanistically-related enzymes. In rats with diet-induced obesity, ND-630 reduced hepatic steatosis, improved insulin sensitivity, and reduced weight gain, suggesting ACC inhibition may be useful in treating metabolic disorders, including type 2 diabetes mellitus, and fatty liver disease.

Synonyms
ND630
Product Info
Storage and Usage
Citations
Formula

C28H31N3O8S

MW
569.63
CAS Registry #
1434635-54-7
References
1. Harriman, G., et al., PNAS. 2016; 113 (13): E1796-E1805.